Roth Capital Initiates Coverage On Rapid Micro Biosystems with Buy Rating, Announces Price Target of $3

Benzinga Newsdesk www.benzinga.com Neutral 56.6%

Neg 0% Neu 56.6% Pos 0%

Roth Capital analyst Max Masucci initiates coverage on Rapid Micro Biosystems (NASDAQ:RPID) with a Buy rating and announces Price Target of $3.